414 related articles for article (PubMed ID: 25752392)
1. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
Kundapur V; Ellchuk T; Ahmed S; Gondi V
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
[TBL] [Abstract][Full Text] [Related]
2. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
Korkmaz Kirakli E; Oztekin O
Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
[TBL] [Abstract][Full Text] [Related]
3. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.
Harth S; Abo-Madyan Y; Zheng L; Siebenlist K; Herskind C; Wenz F; Giordano FA
Radiother Oncol; 2013 Oct; 109(1):152-8. PubMed ID: 24100152
[TBL] [Abstract][Full Text] [Related]
4. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
6. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
7. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
8. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
10. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
[TBL] [Abstract][Full Text] [Related]
11. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
[TBL] [Abstract][Full Text] [Related]
12. Radiological distribution of brain metastases and its implication for the hippocampus avoidance in whole brain radiotherapy approach.
Han YM; Cai G; Chai WM; Xu C; Cao L; Ou D; Chen JY; Kirova YM
Br J Radiol; 2017 Nov; 90(1079):20170099. PubMed ID: 28830202
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
Zhao R; Kong W; Shang J; Zhe H; Wang YY
Clin Lung Cancer; 2017 Mar; 18(2):127-131. PubMed ID: 28340924
[TBL] [Abstract][Full Text] [Related]
14. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
16. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
[TBL] [Abstract][Full Text] [Related]
19. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
20. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
